The complainant reported that a progav 2.0 with shunt assistance 20 (part # fx413t) (ref.Associated mdr id 3004721439-2020-00182) and prechamber (part # fv035t) were implanted in a patient on (b)(6) 2019.Reportedly, contrast medium was injected into the device, which revealed that the flow was blocked at the location of the shunt valve.The patient underwent revision surgery on (b)(6) 2020.No known patient complications.No further additional information is currently available.Associated medwatch: 3004721439-2020-00182.
|
Investigation: visual inspection: the following observations were made during the visual inspection: significant deposits are visible within the reservoir.Permeability test: the test did not show any flow, because the deposits placed in front of the outlet spout and blocked the prechamber, thus preventing drainage.Results: based on our investigation, we are able to substantiate the claim of "blockage".We are assuming that the deposits detected within the prechmaber have caused the functional impairment.Deposits caused by natural substances in the cerebrospinal fluid, such as protein, blood or tissue particles, are among the known and unavoidable risks and side effects of hydrocephalus therapy.From our point of view, no further regulatory actions are required.Same patient medwatch: #3004721439-2020-00182.
|